<DOC>
	<DOCNO>NCT00651651</DOCNO>
	<brief_summary>The purpose study compare Symbicort monocomponents budesonide formoterol treatment asthma child adult</brief_summary>
	<brief_title>Efficacy Symbicort Versus Its Monocomponents - SPRUCE 80/4.5</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>At least 6 year age Diagnosis asthma Baseline lung function test result determine protocol require receive treatment inhaled corticosteroid and/or lung treatment specify protocol within timeframe dos specify protocol Severe asthma Has require treatment noninhaled corticosteroid within previous 4 week , sensitivity drug specify protocol require treatment betablockers Had cancer within previous 5 year currently significant disease disorder judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Symbicort</keyword>
	<keyword>budesonide/formoterol</keyword>
	<keyword>budesonide</keyword>
	<keyword>formoterol</keyword>
</DOC>